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H1. Introduction
Enantiopure secondary alcohols are key intermediaries in
the synthesis of a large number of pharmaceutical prod-
ucts.1,2 In particular, non-racemic alcohols (or their derived
amines) containing heterocyclic fragments are known for
their biological activity.3–5 The borane-mediated reduction
of prochiral ketones catalyzed by organoboranes, speciﬁ-
cally the well-known 1,3,2-oxazaborolidines,6–8 have
become the preferred approach to obtain non-racemic
alcohols due to their high enantioselectivity, predictable
absolute stereochemistry, ease of handling and operation,
and low environmental impact. However, ketones contain-
ing a heteroatom can form borane complexes that not only
decrease the borane source but also compete with the enan-
tioselective carbonyl reduction.5 Acetylpyridines were
reduced with borane employing 20 mol % of B-Me CBS
catalyst, but the process resulted in a low selectivity
(<52% ee). A stoichiometric amount of catalyst increased
the % ee only modestly.9 Masui10 introduced a more reac-
tive oxazaborolidine system generated in situ from 10%
diphenyl prolinol and trimethylborate and successfully
reduced 3- and 4-acetyl heteroaryl ketones with high to
excellent enantioselectivity. However, to achieve good
selectivity for the 2-acetyl analogues, a stoichiometric
amount of the aminoalcohol was required. In related work,
protection of the pyridine nitrogen by a methyl or allylic0957-4166  2007 Elsevier Ltd.
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Open access under CC BY-NC-ND license.group signiﬁcantly increased the enantioselectivity of
non-enolizable diaryl- or pyridylaryl ketones.11
Recently, we reported the synthesis of a series of stable
spiroborate esters derived from non-racemic 1,2-amino-
alcohols and ethylene glycol. These compounds, shown in
Figure 1, were fully characterized by 1H, 13C, and 11B
NMR, HRMS, IR, speciﬁc rotation, and mp.12 All
exhibited high eﬃciency and enantioselectivity as cata-
lysts for the borane-mediated asymmetric reduction of
acetophenone.54
Figure 1. Chiral spiroborates derived from non-racemic 1,2-amino-
alcohols.
Table 2. Studies on the reduction of 3-acetylpyridine employing diﬀerent
catalytic loads of 1
Entry Catalyst 1 (mol %) Yield (%) eec (%)
1 20 84a 91
2 10 89a 91
3 5 94a 90
4 2.5 95a 89
5 1 93b 87
V. Stepanenko et al. / Tetrahedron: Asymmetry 18 (2007) 2738–2745 2739Herein, we report a systematic study of the asymmetric
borane-mediated reduction of acetylpyridines and related
heterocyclic ketones using the spiroborate esters 1–5 as
catalysts. These spiroborates are crystalline compounds
that can be stored for long periods of time (>1 y). More-
over, spiroborate 5 was exposed to moist air at 25 C for
over 24 h, without signiﬁcant hydrolysis or decomposition
being observed by 1H, 13C, and 11B NMR analysis.6 0.5 93b 84
7 0.25 96b 81
8 0.1 91b 65
a Puriﬁed by column chromatography.
b Puriﬁed by distillation.
c By GC of O-acetyl derivative on a CP-Chiralsil-DexCB column.
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e2. Results and discussion
Initially, we studied the asymmetric reduction of 3-acetyl-
pyridine 6 using spiroborates 1–5. The reduction was
carried out with BH3–SMe2 (1.6 equiv) and 10 mol % of
the catalyst at room temperature. The enantiopure 1-(3-
pyridyl)ethanol 7 was isolated after the reaction mixture
was quenched with methanol at 0 C, left overnight at
reﬂux temperature, concentrated under vacuum, and puri-
ﬁed by column chromatography on deactivated aluminum
oxide (method a). The results are summarized in Table 1.
Although catalysts 1–4 (entries 1–4) provided good enantio-
selectivities (i.e., >90% ee), spiroborate 5 was particularly
eﬀective, (99% ee) for the reduction of 6 (entry 5).Table 1. Reduction of 3-acetylpyridine with spiroborate esters 1–5 as
catalysts in THF at 25 C using BH3–SMe2
N
O
BH3.DMS / THF, rt
6 7N
*
OH
Cat. 1-5 (10% mol)
Entry Cat. mol % Yield (%) eea (%) Conf.
1 1 10 89 91 (R)-(+)
2 2 10 85 96b (S)-()
3 3 10 94 96c (R)-(+)
4 4 10 88 92 (S)-()
5 5 10 80 99 (R)-(+)
a By GC of O-acetyl derivatives on a CP-Chiralsil-DexCB column.
b By GC on a chiral column.
c By 31P NMR of phosphonate (CDA).14
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Figure 2. Amount of catalyst 1 versus % ee of 1-(3-pyridyl)ethanol.
Table 3. Solvent eﬀects on the reduction of 3-acetylpyridine with 1 mol %
of catalyst 1
Entry Solvent Yielda (%) eeb (%)
1 THF 93 87
2 Dioxane 87 84
3 t-Butylmethylether 93 71
4 CH2Cl2 89 63
5 Toluene 65 61
a Isolated yield.
b By GC of O-acetyl derivative on a CP-Chiralsil-DexCB column.Several studies were carried out to determine the minimum
eﬀective catalyst loading, the best reaction temperature and
solvent, as well as borane source. For these studies, we
chose to employ 3-acetylpyridine and spiroborate 1, which
is derived from the inexpensive and commercially available,
norephedrine. The optimal amount of 1 was determined
through the reduction of 3-acetylpyridine with BH3–SMe2
(1.6 equiv) by varying the amount of catalyst from 0.1 to
20 mol % at 25 C. The results are shown in Table 2. The
reduction of 3-acetylpyridine with 20 mol % of catalyst 1
aﬀorded the corresponding alcohol in 91% ee and 84% iso-
lated yield (entry 1). Decreasing the catalyst to 1 mol %
slightly decreased the selectivity to 87% ee (entry 5). When
smaller amounts of catalyst (>1 mol %) were used, the iso-
lation process was more convenient by vacuum distillation
in a Kugelrohr apparatus (method b), usually increasing
the chemical yield.To illustrate the cut-oﬀ eﬀect for catalyst 1, the correlation
curve between the amount of catalyst and the enantiopurity
of 1-(3-pyridyl)ethanol is presented in Figure 2.Solvents play a key role in the degree of enantioselectivity
achieved by the oxazaborolidine catalyzed borane-medi-
ated reductions.6,7 Therefore, we studied the 3-acetylpyri-
dine reduction in diﬀerent solvents using only 1 mol % of
spiroborate ester 1 to enhance the diﬀerences in enantio-
selectivity. As shown in Table 3 (entry 1), THF was the
most eﬀective solvent in terms of chemical yield and enantio-
selectivity. Less polar solvents such as dichloromethane
and toluene led to a decrease in the enantioselectivity of
the reaction.Temperature and a diﬀering borane source are also critical
factors in the enantioselectivity of carbonyl and oxime
reductions.6,12,13 To amplify these changes, the reduction of
Table 4. Eﬀect of temperature and diﬀerent borane sources on the
reduction of 3-acetylpyridine in THF with 0.5 mol % of catalyst 1
Entry Reaction conditions eea (%)
1 BH3–SMe2, 0 C 61
2 BH3–SMe2, 50 C 71
3 BH3–SMe2, 25 C 84
4 BH3–THF,
b 25 C 15
5 BH3–THF,
c 25 C 65
6 BH3–DEA, 25 C 65
aDetermined by GC of O-acetyl derivatives.
b Borane was stabilized with 0.005 M NaBH4.
c Borane was stabilized with <0.005 M N-isopropyl N-methyl-tert-butyl
amine.
2740 V. Stepanenko et al. / Tetrahedron: Asymmetry 18 (2007) 2738–27453-acetylpyridine was performed with 0.5 mol % spiroborate
1 in THF. The results are summarized in Table 4. Optimal
selectivity was achieved at 25 C in THF using BH3–SMe2
(entry 3, 84% ee). The use of BH3–THF stabilized with
NaBH4 (entries 4) resulted in a dramatic decrease in the
enantioselectivity.7,15
Further studies were extended to the reduction of the 2-, 3-,
and 4-acetylpyridines with catalyst 5. The results for the 3,
and 4-acetylpyridines are shown in Table 5. Initially, the
solvent dilution eﬀect on the degree of selectivity was deter-
mined for the reduction of 3-acetylpyridine with 1 mol % of
spiroborate ester 5. When the catalyst was diluted ten
times, the enantiomeric excess dropped from 98% to 82%
ee.Table 5. Enantioselective reduction of 3- and 4-acetylpyridine with
catalyst 5
N
O O
B
O
O
N
H
Ph
Ph
N
OH
BH3.DMS / THF
5H
(R)-1-(3-pyridyl)ethanol 7
(R)-1-(4-pyridyl)ethanol 8
Entry Cat. 5 (mol %) Pyridine Yield (%) eea (%)
1 10 3-Acetyl 80 99
2 5 3-Acetyl 93 99
3 2.5 3-Acetyl 91 98
4 1.0 3-Acetyl 96 98
5 0.5 3-Acetyl 93 94
6 10 4-Acetyl 88 99
7 2.5 4-Acetyl 95 99
8 1 4-Acetyl 92 99
a By GC of O-acetyl derivatives on a chiral column.
Table 6. Enantioselective reduction of 2-acetylpyridine using spiroborates
1 and 5 as catalysts
N N
O
*
OH
Cat./THF
2 BH3-X
9 10
Entry Catalyst mol %
catalyst
Reagent Yield (%) % eea,
(conf.)
1 1 10 BH3–SMe2 59 8 (R)
2 1 25 BH3–SMe2 54 16 (R)
3 1 100 BH3–SMe2 58 40 (R)
4 5 10 BH3–SMe2 — 10 (R)
5 5 50 BH3–SMe2 56 58 (R)
6 5 100 BH3–SMe2 82
b 93 (R)
7 5 100 BH3–DEA 79
b 78 (S)
a By GC on a chiral column (CP-Chiralsil-DexCB) of O-acetate.
b The product was isolated as an O-acetate derivative.The reduction of 3-, and 4-acetylpyridines with spiroborate
5 was successfully performed with less than 5 mol % pro-
viding the enantiopure pyridyl ethanols (>98% ee, Table
5, entries 4 and 8) in excellent yield. Remarkably, the
reduction of 4-acetyl pyridine at 25 C in THF using
BH3–SMe2 aﬀorded 99% ee even with 1 mol % of catalyst.
In addition, using 10% catalyst 3 for the reduction of 3-,
and 4-acetylpyridine, aﬀorded also high enantioselectivity:
97.2% ee and 96.4% ee, respectively, determined by 31PNMR analysis of the phosphonate derivatives, which were
prepared by the Alexakis method.14
The asymmetric borane reduction of 2-substituted hetero-
aryl ketones is more challenging since borane complexed
to the pyridyl nitrogen can reduce the carbonyl group
through an intramolecular process, thereby decreasing the
enantioselectivity of the reaction. Initially, 2-acetylpyridine
9 was reduced with 0.1 equiv of catalyst 1 and 2 equiv of
borane–SMe2 in THF at room temperature.
Quenching the reaction mixture with methanol (procedure
a) for the isolation of 1-(2-pyridyl) ethanol 10 was not eﬀec-
tive, perhaps, due to the formation of the stable alkoxy-
borane complexes. The product was successfully obtained
after acid hydrolysis and continuous extraction from the
aqueous phase for 3 days with diethyl ether. Nevertheless,
the isolated yield was modest. The selectivity was also low,
even when 1 equiv of spiroborate 1 was used (Table 6,
entries 1–3). Several electrophiles, such as TMSCl, BF3,
B(OMe)3, and BEt3, were employed to protect the pyridyl
nitrogen. The enantioselectivity, however, was not
improved and other side products were observed. The
reduction of 2-acetyl pyridine with 1 equiv of catalyst 5
and 2 equiv of borane–SMe2 achieved 93% ee (entry 7).
An attempt was made to use the catalyst 5 more eﬃciently
by adding a second load of 2-acetylpyridine after the initial
asymmetric reduction was performed, before quenching the
reaction. Unfortunately, the enantioselectivity dropped
from an initial 93% ee to 58% ee. Borane–DEA and cata-
lyst 5 aﬀorded 78% ee (entry 8). Surprisingly, when the
reducing reagent was BH3–DEA, the absolute conﬁgura-
tion of the product was (S), the opposite compared to that
obtained with borane–SMe2. Since alcohol 10 is water-sol-
uble, the chemical yield was improved by its isolation as its
acetyl ester (entries 6 and 7).Other important heteroaryl ketones were reduced with
borane employing the spiroborate 5 catalyst to expand
the scope of the reaction. The results are presented in Table
7. The 5-acetyl-2-methoxypyridine was eﬀectively reduced
with only 1 mol % of catalyst 5 (98% ee, entry 1). The
Table 7. Enantioselective reduction of other heterocyclic ketones using spiroborates 3 and 5 as catalysts
N
OH
S
N
OH
OH
N
N
11
1413
NMeO
OH
12
H
Entry Substrate Catalyst Prod mol % Yield (%) eea (%)
1 5-Acetyl-2-methoxy pyridine 5 11 1 77 98b
2 2-Acetylphenothiazine 5 12 1 94 94
3 2-Acetylphenothiazine 5 12 10 97 >99
4 2-Acetylphenothiazine 3 12 10 95 >99
5 4 0-(Imidazol-1-yl)acetophenone 5 13 1 85 90
6 4 0-(Imidazol-1-yl)acetophenone 5 13 10 76 92
7 3-Benzoylpyridine 5 14 10 83 83
a By 31P NMR of phosphonate (CDA) derivative.14
b By GC of O-acetyl derivatives on a chiral column.
V. Stepanenko et al. / Tetrahedron: Asymmetry 18 (2007) 2738–2745 2741initial reduction of 2-acetylphenothiazine using 1 mol % of
catalyst 5 aﬀorded 94% ee, but with 10 mol % of catalyst
provided highly enantiopure alcohol 12 (>99% ee). Inter-
estingly, spiroborate ester 3 derived from (S)-diphenyl
valinol also provided 12 with similarly high selectivity. In
the reduction of 4 0-(imidazol-1-yl) acetophenone with
10 mol % of catalyst 5, the enantiomeric excess of alcohol
13 increased slightly to 92%. The solubilities of these large
heterocyclic compounds play a crucial role since they
require more dilute solutions which aﬀects the eﬀectiveness
of the catalyst. The reduction of 3-benzoylpyridine with
10 mol % of 5 produced (R)-phenyl pyridyl methanol 14
in good yield with 83% ee (entry 7).3. Conclusion
Prochiral ketones containing heteroaromatic fragments
undergo asymmetric reduction with a high degree of
enantioselectivity using the novel spiroborates derived
from non-racemic 1,2-amino alcohols. This work demon-
strates that these crystalline spiroborates can be success-
fully used as highly eﬃcient chiral transfer reagents
employing only 1 mol % of the catalyst in some cases.
The synthesis of important enantiopure alcohols with
heterocyclic groups was also achieved in high chemical
yield by a rapid and practical procedure for small and
potentially large-scale industrial use.4. Experimental
All reactions were performed in oven-dried glassware
(120 C) under an N2 atmosphere. Air- and moisture sensi-tive reagents and solvents were transferred via syringe. All
reagents were obtained commercially unless otherwise
noted. Common solvents were dried and distilled by stan-
dard procedures. Anhydrous borane reagents were pur-
chased from Aldrich and used directly from the sealed
bottle. Chromatographic puriﬁcation of products was
accomplished using ﬂash chromatography on a Merck
Silica Gel, Si 60 (200–400 mesh) or Fisher, Activity I,
60–325 mesh acid alumina oxide deactivated by 3% of
water, 25–30 g; hexane–AcOEt 100:1 to 1:1 using HPLC
grade solvents. Thin layer chromatography (TLC) was per-
formed on Merck Silica Gel plates. Spots were made visible
with a UV lamp and/or I2 vapors. Infrared analyses were
performed in a Termo Nicolet 670 FT-IR. 1H, 13C, and
11B NMR spectra were recorded on a Bruker Avance
400 MHz spectrometer with standard pulse sequences
operating at 400.152 MHz, 100.627 MHz, 128.384 MHz,
and 161.992 MHz for 1H, 13C, 11B, and 31P, respectively,
in CDCl3. Chiral gas chromatography analysis was pro-
cessed on a Hewlett Packard GC 5890 equipped with a
Chrompack Chiralsil-Dex-CB column (30 m · 0.25 mm ·
0.25 lm). GC–MS analysis was processed on a Finnigan
Trace GC/Polaris Q Mass detector using a Restek RTX-
5MS column. A Perking Elmer Polarimeter Model 341
was used for optical rotation analysis.
4.1. (±)-1-(6-Methoxypyridin-3-yl)-ethanol 11
To 1-(6-methoxypyridin-3-yl)ethanone (151 mg, 1 mmol)
in THF (5 mL) and MeOH (1 mL) was added solid sodium
borohydride (38 mg, 1 mmol) at 25 C. After the reaction
mixture was stirred for 1 h, the solvents were evaporated
and the residue dissolved in water (10 mL). Solid NaCl
was added, followed by ammonia hydroxide solution
2742 V. Stepanenko et al. / Tetrahedron: Asymmetry 18 (2007) 2738–2745(30% in water, 1 mL). The product was extracted with ether
(5 · 10 mL) and dried over Na2SO4. The solvents were
removed under vacuum; the residue was distilled in a
Kugelrohr apparatus under vacuum to give the ﬁnal prod-
uct as a colorless oil (133 mg, 87%).
4.2. General preparation of O-acetyl derivatives for GC-
analysis of pyridyl ethanols
To a solution of the racemic or enantio-enriched alcohol
(20 mg, 0.16 mmol) in dry dichloromethane (1 mL,) in a
2 mL vial was added neat triethylamine (0.1 mL,
0.72 mmol), acetic anhydride (0.1 mL, 1.06 mmol), and a
small crystal of DMAP (5 mg, 0.04 mmol). The mixture
was left at 25 C for 5 min. After the reaction was complete
(followed by TLC, hexane/AcOEt, 1:1), the mixture was
transferred to a second 10 mL vial with H2O (2.5 mL)
and shaken for 5 min. Solid Na2CO3 (2 g) was carefully
added by small portions and left for 5 min, shaking from
time to time. Extreme evolution of gas was observed. The
O-acetyl derivative was extracted with diethyl ether
(4 mL) and the organic phase was transferred with a Pas-
teur pipette to another vial and analyzed by chiral GC.
4.3. Synthesis of chiral derivatizing agent (CDA) 18 for
enantiomeric analysis of alcohols by 31P NMR14
4.3.1. Dicarbamate 16. In a 250 mL round ﬂask, a solu-
tion of (R,R)-()-cyclohexane-1,2-diamine 15 (10 g,
88 mmol) in toluene (130 mL) was stirred and cooled to
0 C. Ethyl chloroformate (18.1 mL, 190 mmol) and
NaOH (7.6 g, 190 mmol) in water (8.3 mL) were added
simultaneously. The temperature should not reach more
than 10 C during the addition. The mixture was then
stirred overnight and the precipitate was ﬁltered and rinsed
with CH2Cl2. The solid was continuously extracted in a
Soxhlet system overnight with CH2Cl2 (150 mL). The solu-
tions were then mixed, dried over MgSO4, and concen-
trated under vacuum. The dicarbamate 17 was obtained
as a white solid (89% yield). 1H NMR (400 MHz, CDCl3):
d 1.23 (m, CH3); 1.72 (d, CH2); 2.0 (d, CH2); 3.33 (m, CH2),
4.09 (m, CH), 4.97 (N–H); 13C NMR (100 MHz, CDCl3): d
14.6 (OCH2CH3), 24.8, 32.9, 55.4 (NCH), 60.7
(OCH2CH3), and 157.0 (C@O).
NH2
NH2
H
N
N
H
C
C
O
O
OEt
OEt
Cl OEt
O
NaOH/Toluene
5 LiAlH4
NHMe
NHMe
THF
17
15 16
4.3.2. (R,R)-N,N 0-Dimethyl-cyclohexane-1,2-diamine 17.
To a solution of LiAlH4 (14.89 g, 392.5 mmol) in dry
THF (300 mL) was slowly added compound 16 (20.29 g,78.5 mmol) in dry THF (50 mL) at 25 C. The mixture
was stirred for 18 h at reﬂux temperature and cooled to
0 C. Ethylenediamine (20 mL) was slowly added to the
mixture, followed by a 15% NaOH aqueous solution
(20 mL) over 1 h. The precipitate was removed through a
Celite pad, and the ﬁltrate was concentrated under vac-
uum. The Celite was then extracted overnight with ethyl
ether using a Soxhlet apparatus. The ether solutions were
combined, dried over K2CO3, ﬁltered, and concentrated.
After vacuum distillation through a 10 cm Vigreux column,
the colorless diamine 17 was obtained in a 61% yield. Bp
83 C (20 mmHg); 1H NMR (400 MHz, CDCl3): d 0.98
(m, 1H, CH); 1.25 (m, 1H, CH); 1.51 (s, 1H, N–H); 1.75
(m, 1H, CH); 2.04 (m, 1H, CH); 2.12 (m, 1H, CH); 2.42
(s, 3H, CH3);
13C NMR (100 MHz, CDCl3): d 25.0
(NHCH3), 30.8, 33.6, 63.2 (NHCH).
N
P
N
Cl
TEA, CDCl3 N
P
N
O
Me
Me
Me
Me
18 19
NHMe
NHMe
17
PCl3
TEA
OH
R1
R
R1
*
R *
4.3.3. Chloro-1,3-dimethyl-octahydro-benzo[1,3,2]diaza-
phosphole CDA 18. To a solution of chiral diamine 17
(0.50 g, 3.50 mmol) in CH2Cl2 (10 mL) in 25 mL ﬂask
was added triethylamine (2.44 mL, 17.5 mmol), followed
by the addition of PCl3 (1.22 mL, 14.0 mmol). The mixture
was concentrated under vacuum to eliminate the excess of
PCl3. The CDA 18 in CDCl3 (10 mL) was prepared as a
standard solution (0.35 M) for further diastereoisomeric
analyses.
4.3.3.1. CDA 18 preparation in a NMR tube. In a dried
NMR tube were placed the chiral alcohol (0.02 g,
0.141 mmol) and CDCl3 (0.4 mL). The tube was shaken
until complete dissolution. Et3N (0.1 mL, 0.717 mmol)
was added with a micro syringe, followed by the addition
of PCl3 (0.05 mL, 0.573 mmol). The NMR tube was care-
fully shaken as an exothermic reaction takes place. The
mixture was concentrated under vacuum. The same
amounts of CDCl3 and triethylamine were added again
to the NMR tube. The in situ solution of CDA 18 was
immediately used. A 31P NMR spectrum was recorded to
check the reagent; 31P NMR (161.992 MHz, CDCl3); d 182.4.3.4. General procedure for derivatization for 31P NMR
analysis. To the CDA 18 (0.141 mmol) in a NMR tube
was added triethylamine (0.1 mL) and diamine 17 (8–
10 lL). The solution was shaken and the 31P NMR spec-
trum was recorded and analyzed. The conversion of 19 to
the corresponding thiophosphoramidates with sulfur (S8)
powder was carried out in the same NMR tube for a sec-
ond 31P NMR determination in cases where the signals
were not resolved. A racemic sample of each alcohol was
used to identify the relevant signals before each non-race-
mic derivative was analyzed. This was also necessary to
ensure that the alcohol enantiomers react at the same rate
with the CDA. 31P NMR (161.992 MHz, CDCl3); d (ppm)
derivative of (±)-1-(4-pyridyl)ethanol 8, 141.23 and 140.13
(Dd = 1.10); (±)-1-(3-pyridyl)ethanol 7, 141.58 and 140.32
V. Stepanenko et al. / Tetrahedron: Asymmetry 18 (2007) 2738–2745 2743(Dd = 1.26); (±)-1-(2-pyridyl)ethanol 10, 141.11 and 138.23
(Dd = 2.88).
4.4. (R)-(+)-1-(3-Pyridyl)-ethanol 7 using 1 mol % of cata-
lyst 5
A borane–SMe2 complex (10 M, 1.6 mL, 16.0 mmol) was
added to a solution of (S)-2-[(1,3,2-dioxaborolan-2-
yloxy)diphenylmethyl]pyrrolidine 512 (32 mg, 0.10 mmol)
in dry THF (5 mL) at 25 C and the mixture was stirred
for 1 h. A solution of 3-acetylpyridine (1.21 g, 10.0 mmol)
in THF (5 mL) was added for 5 h using an infusion pump.
The reaction mixture was stirred at rt over 1 h, then cooled
at 0 C and quenched with methanol (10 mL). After reﬂux-
ing for 12 h, the solvents were removed under vacuum; the
residue was distilled in a Kugelrohr apparatus under vac-
uum to give the ﬁnal product as colorless oil (1.18 g,
96%). 1H NMR (400 MHz, CDCl3): d 1.47 (d, J =
6.5 Hz, 3H, Me), 4.88 (q, J = 6.5 Hz, CHMe), 6.02 (br s,
1H, OH), 7.22 (m, 1H, CHAr), 8.29 (m, 1H, CHAr), 8.41
(m, 1H, CHAr);
13C NMR (100 MHz, CDCl3): d 25.3,
67.1, 123.6, 133.7, 142.2, 146.9, 147.6. Chiral GC of O-
acetyl derivative (tR 12.05 min) indicated 98.2% ee.
½a23D ¼ þ41:1 (c 3.6, CHCl3). Lit.16 ½a20D ¼ þ52:4 (c 1.40,
CHCl3) for >95% ee.
4.5. (R)-(+)-1-(4-Pyridyl)-ethanol 8 using 1 mol % of cata-
lyst 5
Borane–SMe2 complex (10 M, 1.6 mL, 16.0 mmol) was
added to a solution of (S)-2-[(1,3,2-dioxaborolan-2-
yloxy)diphenylmethyl]-pyrrolidine 512 (32 mg, 0.10 mmol)
in dry THF (5 mL) at 25 C. A solution of 4-acetylpyridine
(1.21 g, 10.0 mmol) in THF (5 mL) was added for 5 h using
an infusion pump. The reaction mixture was stirred at 25 C
for 1 h, cooled at 0 C and quenched with methanol
(10 mL). After reﬂuxing for 4 h, the mixture was analyzed
by 11B NMR and the N–BH3 complex signal was observed
at 13.28 ppm. More MeOH (10 mL) was added and re-
ﬂuxed for 12 h. The solvents were removed under vacuum
and the residue was distilled in a Kugelrohr apparatus un-
der vacuum to give pure (R)-1-(4-pyridyl)ethanol as a white
crystalline material (1.13 g, 92%); (mp: 55–58 C). 1H NMR
(400 MHz, CDCl3): d 1.39 (d, J = 6.4 Hz, 3H); 4.80 (q,
J = 6.4 Hz, 1H); 5.1 (s, 1H); 7.22 (d, J = 6.0 Hz, 2H); 8.31
(d, J = 5.6Hz, 2H); 13C NMR (100 MHz, CDCl3): d 25.0
(CH3); 68.2 (C–H(OH)); 120.6 (CHAr); 149.0 (CHAr);
156.0. Chiral GC of O-acetyl derivative (tR 12.39 min)
indicated 99% ee. ½a23D ¼ þ49:0 (c 2.5, CHCl3). Lit.16½a20D ¼ þ42:5 (c 1.04, MeOH) for >95% ee.
4.6. (R)-(+)-1-(2-Pyridyl)-ethanol 10 using 100 mol % cata-
lyst 5
Borane–SMe2 complex (10 M, 0.5 mL, 5.00 mmol) was
added to a solution of (S)-2-((1,3,2-dioxaborolan-2-
yloxy)diphenylmethyl)pyrrolidine 512 (808 mg, 2.50 mmol)
in dry THF (5 mL) at rt for 4 h. A solution of 2-acetylpyr-
idine (303 mg, 2.50 mmol) in THF (2 mL) was added for
1 h using an infusion pump. The reaction mixture was stir-
red for 1 h at 25 C, cooled to 0 C, quenched with metha-
nol (5 mL), and reﬂuxed for 12 h. The solvents wereremoved under vacuum and the residue dissolved in
CH2Cl2 (10 mL). Acetic anhydride (2 mL) and triethyl-
amine (2 mL) were added followed by DMAP (5 mg). After
stirring at 25 C for 1 h, the reaction mixture was added to
water (15 mL) and quenched with solid Na2CO3 (10 g). The
organic phase was separated and the product was extracted
with ethyl ether (5 · 10 mL). The combined organic
extracts were dried with MgSO4 and concentrated in vac-
uum. The product was puriﬁed by column chromatography
(Al2O3 deactivated by 3% of water, 35 g; hexane and
hexane–AcOEt 100:1 to 10:1). The main fractions were
concentrated under vacuum and the residue was distilled
in Kugelrohr apparatus under vacuum to give the ﬁnal
product as a colorless oil (338 mg, 82%). 1H NMR
(400 MHz, CDCl3): d 1.61 (d, J = 6.8 Hz, 3H, CHMe),
2.13 (s, 3H, OAc), 5.91 (q, J = 6.8 Hz, 1H, CHMe), 7.20
(m, 1H, CHAr), 7.33 (d, J = 8Hz, 1H, CHAr), 7.68 (m,
1H, CHAr), 8.58 (m, 1H, CHAr);
13C NMR (100 MHz,
CDCl3): d 20.7, 21.3, 73.1, 120.5, 122.7, 136.7, 149.4,
160.3, 170.3. Chiral GC of O-acetyl derivative indicated
92.9% ee. ½a23D ¼ þ90:1 (c 2.5, CHCl3). Lit.16 ½a20D ¼þ102:3 (c 1.27, CHCl3) for >95% ee.
4.7. (R)-(+)-1-(6-Methoxy-pyridin-3-yl)-ethanol 1117 using
1 mol % of catalyst 5
Borane–SMe2 complex (10 M, 0.99 mL, 9.9 mmol) was
added to a solution of (S)-2-[(1,3,2-dioxaborolan-2-
yloxy)diphenylmethyl]pyrrolidine 512 (19.9 mg, 0.06 mmol)
in dry THF (3 mL) at rt and the mixture was stirred for 1 h.
A solution of 1-(6-methoxypyridin-3-yl)ethanone (930 mg,
6.16 mmol) in THF (5 mL) was added for 5 h using an
infusion pump. The reaction mixture was stirred at 25 C
over 1 h, then cooled to 0 C and quenched with methanol
(5 mL). After reﬂuxing for 12 h, the solvents were removed
under vacuum and the product was puriﬁed by column
chromatography (Al2O3 deactivated by 3% of water, 25 g;
hexane–AcOEt 100:1 to 1:1). The main fractions were
concentrated under vacuum and the residue was distilled
in a Kugelrohr apparatus (oven temperature 210 C) under
vacuum (1 mmHg) to give the ﬁnal product as a colorless
oil (726 mg, 77%). IR (CaF2, ﬁlm, cm
1): 3355 (br, OH),
2974, 2948, 1609, 1496, 1325, 1286, 1253, 1094, 1029. 1H
NMR (400 MHz, CDCl3): d 1.45 (d, J = 6.5 Hz, 3H,
CHMe), 3.16 (br s, 1H, OH), 3.89 (s, 3H, OMe), 4.81 (q,
J = 6.5, 1H, CHMe), 6.70 (d, J = 8.6 Hz, 1H, CHAr),
7.60 (m, 1H, CHAr), 8.01 (m, 1H, CHAr);
13C NMR
(100 MHz, CDCl3): d 24.8, 53.5, 67.6, 110.8, 133.7, 136.5,
144.1, 163.7. Chiral GC of O-acetyl derivative indicated
98.0% ee. ½a23D ¼ þ33:7 (c 2.7, CHCl3).
4.8. (R)-(+)-1-(10H-Phenothiazin-2-yl)-ethanol 12 using
10 mol % catalyst 5
A borane–SMe2 complex (10.0 M, 2.0 mL, 20 mmol) was
added to a solution of spiroborate 5 (0.323 g, 1.0 mmol) in
dry THF (30 mL) at 25 C and the mixture was stirred for
about 15 min. A solution of 2-acetyl-1-phenothiazine
(2.413 g, 10.0 mmol) in dry THF (40 mL) was added to
the reaction mixture during for 1 h using an infusion pump.
The mixture was allowed to react overnight. The reaction
was cooled to 0 C, quenched with MeOH (20 mL), and
2744 V. Stepanenko et al. / Tetrahedron: Asymmetry 18 (2007) 2738–2745heated at reﬂux for 2 h. The solvents were removed in vacuo.
The crude product was puriﬁed bywashing the solid 1-(10H-
phenothiazin-3-yl)ethanol with dichloromethane (50 mL)
several times to remove traces of impurities and dried over-
night under high vacuum obtaining pure (R)-1-(10H-pheno-
thiazin-2-yl)-ethanol (2.375 g, 97.6% yield). Mp 134–
136 C.18 IR (cm1): 3396 (NH), 3314 (OH), 1091 (C–O).
1H NMR (400 MHz, (DMSO)): d 1.27 (d, J = 6.4 Hz, 3H,
CH3); 4.57 (m, 1H, C–HOH); 5.10 (d, J = 4.0 Hz 1H,
–OH); 6.7–7.0 (m, 7H, Ar); 8.55 (s, 1H, NH). 13C NMR
(100 MHz, DMSO): d 26.2, 68.1, 112.0, 114.6, 114.9,
117.0, 119.4, 122.1, 126.2, 126.7, 127.9, 142.4, 142.7,
147.6. 31P NMR (162 MHz, CDCl3): (racemic derivative):
d (ppm) 141.02 and 137.91 (Dd = 3.11). (chiral
alcohol): d (ppm) 137.91 (>99% ee). ½a23D ¼ þ24:0 (c 1.0,
MeOH).
4.9. (R)-(+)-4 0-(Imidozol-1-yl)-phenyl ethanol 13 using
10 mol % catalyst 5
A borane–SMe2 complex (10 M, 2.0 mL, 20.0 mmol) was
added to catalyst 5 (323 mg, 1.0 mmol) in dry THF
(20 mL) at rt. A solution of 4 0-(imidazol-1-yl) acetophe-
none (1.86 g, 10.0 mmol) in THF (20 mL) was added for
5 h using an infusion pump. The reaction mixture was stir-
red at 25 C overnight and then cooled to 0 C and
quenched with methanol (10 mL). After reﬂuxing over-
night, the solvents were removed under vacuum. The crude
product was puriﬁed by ﬂash column chromatography on a
silica column (40 g) using ethyl acetate to give pure 13 as a
white crystalline material (1.40 g, 76%), mp: 118–120 C;
1H NMR (400 MHz, CDCl3): d 1.53 (d, J = 6.4Hz, 3H),
3.7 (br s, 1H), 4.96 (q, J = 6.4 Hz, 1H), 7.14 (s, 1H); 7.24
(s, 1H), 7.32 (d, J = 8.4 Hz, 2H), 7.8 (d, J = 8.4 Hz, 2H),
7.69 (s, 1H); 13C NMR (100 MHz, CDCl3): d 24.5 (CH3);
69.3 (C–H(OH)), 118.3, 121.4, 127.0 (CHAr), 130.0, 135.5,
136.2 (CHAr), 146.0. The product was analyzed by
31P
NMR with a small amount of sulfur; the diastereomers
signals at 86.1 ppm (3.5%) and 85.8 ppm (96%) pro-
vided 92.5% ee. ½a23D ¼ þ31:7 (c 0.40, CHCl3). Lit.19½a17D ¼ 33 (c 0.48, CHCl3) for >98% (by HPLC) for (S)
enantiomer.
4.10. (S)-(+)-Phenyl(pyridin-3-yl)methanol 14 with 10 mol %
catalyst 5
Borane–SMe2 complex (10.0 M, 1.0 mL, 10 mmol) was
added to a solution of spiroborate 5 (0.323 g, 1.0 mmol)
in dry THF (30 mL) at 25 C and the mixture was stirred
for about 15 min. A solution of 3-benzoylpyridine
(1.832 g, 10.0 mmol) in dry THF (10 mL) was added to
the reaction mixture during 1 h. The mixture was allowed
to react overnight. The reaction mixture was cooled to
0 C, then MeOH (20 mL) was added and the mixture
was heated at reﬂux for 8 h. Decomposition of N–BH3
complex was conﬁrmed by 11B NMR and the mixture
was concentrated to colorless oil. The residue was distilled
under high vacuum in the Kugelrohr oven (140 C/
0.7 mmHg) obtaining pure phenyl (pyridin-3-yl)methanol
(1.53 g, 83% yield). 1H NMR (400 MHz, CDCl3): d 4.20
(s, 1H, OH); 5.84 (s, 1H, C–H); 7.23 (m, 1H, C–H), 7.27–
7.38 (m, 5H); 7.71 (m, J = 7.6 Hz, 1H); 8.36 (dd,J = 4.4 Hz, 1H); 8.50 (d, J = 2.4 Hz, 1H); 13C NMR
(100 MHz, CDCl3): d 73.9, 123.5, 126.6, 127.9, 128.7,
134.4, 139.7, 143.2, 148.0, 148.3. Using the in situ CDA
solution a diastereomeric sample was prepared and
analyzed by 31P NMR (161.992 MHz, CDCl3); the enantio-
purity was 83% ee. ½a23D ¼ þ12:0 (c 1.6, CHCl3). Lit.20½a20D ¼ 19:0 (c 1.20, CHCl3) for 75% ee (by HPLC).Acknowledgements
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